Tonix Pharmaceuticals Holding Corp At The June 1st Virtual Investor Summit Transcript
Fred Rockwell from Investor Summit, and I'm excited to introduce Jessica Morris, COO of Tonix Pharmaceuticals. Jessica, please take it.
Great. Thank you very much for the introduction, and it's great to be here presenting virtually at the Investor Summit Conference today. Good morning to everyone. As stated, I'm Jessica Morris, Chief Operating Officer with Tonix Pharmaceuticals. We are a publicly traded company, traded on Nasdaq under the ticker TNXP. So here as our standard public company disclosure, I will be making forward-looking statements today. And I invite you to view our SEC filings for more complete information.
So Tonix is a clinical-stage biopharmaceutical company. And here we have listed our mission, which is to improve population health by inventing and developing innovative therapies as well as vaccines. And we do this using our in-house capabilities as well as collaborations with other companies and academic institutions to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
